The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

Merck & Co., Inc. (NYSE: MRK) is one of the. The company announced that the US FDA approved ENFLONSIA™ (clesrovimab-cfor) for ...

The revamped and “more anti-vax skewed ACIP committee” at the CDC “has a bone to pick with mRNA vaccines,” according to ...

Kennedy’s controversial panel overhaul met its first test. The result? A major win for public health ahead of RSV season.

The recommendation for Enflonsia is indicated for respiratory syncytial virus prevention in infants under eight months of age ...

HSS’ newly formed Advisory Committee on Immunization Practices voted 5-2 to recommend Merck’s respiratory syncytial virus monoclonal antibody drug and against an ingredient in some flu vaccines. The ...

ACIP voted to recommend against anyone — adult, child and pregnant person — receiving a seasonal flu vaccine with the mercury ...